Integra LifeSciences Holdings (IART) is a publicly traded Healthcare sector company. As of May 21, 2026, IART trades at $15.22 with a market cap of $1.10B and a P/E ratio of -2.33. IART moved +7.06% today. Year to date, IART is +22.53%; over the trailing twelve months it is +15.54%. Its 52-week range spans $8.70 to $27.13. Analyst consensus is neutral with an average price target of $15.60. Rallies surfaces IART's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Integra LifeSciences Holdings (IART) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. IART moved +7.06% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $15.22 |
| Market Cap | $1.10B |
| P/E Ratio | -2.33 |
| EPS | $-6.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.13 |
| 52-Week Low | $8.70 |
| Volume | 10 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.64B |
| Net Income | $-495.80M |
| Gross Margin | 51.94% |
8 analysts cover IART: 0 strong buy, 1 buy, 4 hold, 3 sell, 0 strong sell. Consensus rating is neutral. Average price target: $15.60.